Polysaccharide synthesis operon modulates Rickettsia-endothelial cell interactions
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1013277 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Smruti Mishra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Diseases, Stony Brook University, Stony Brook, New York, United States of America. Hauptthemen laut MEDLINE: Operon, Endothelial Cells, Rickettsia Infections, Rickettsia conorii. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Stony Brook University.
Abstract (Originalsprache)
Pathogenic Rickettsia species target vascular endothelial cells and cause systemic vasculitis. As obligate intracellular bacterial pathogens, Rickettsia must secure nutritional resources within the cytoplasm of endothelial cells while simultaneously subverting the innate immune defense system. With advances in rickettsial and host genetics, recent studies have identified novel molecular mechanisms involved in the complex interactions between Rickettsia and endothelial cells. However, it remains unclear how Rickettsia shields pathogen-derived immune stimulants, such as lipopolysaccharides (LPS) and peptidoglycan fragments, from immune recognition during intracellular replication. Prior work described two Rickettsia conorii variants with kkaebi transposon insertions in the polysaccharide synthesis operon ( pso ). Biochemical and immunological analyses revealed that pso is responsible for the biosynthesis of O-antigen (O-Ag) and the proper assembly of surface proteins. In the present work, we document that pso variant HK2 exhibits reduced capacities to adhere to and invade microvascular endothelial cells. Despite the low intracellular abundance, HK2 induced significantly higher levels of proinflammatory cytokines and chemokines, leading to premature cell death. Notably, HK2 exhibited defective intracellular survival in bone marrow-derived macrophages. This inability to dampen endothelial cell-mediated immune stimulation and resist macrophage-induced bactericidal activities resulted in the rapid elimination of viable Rickettsia in the mouse model of spotted fever. Further, when tested as a live-attenuated vaccine, HK2 elicited robust protective immunity against lethal spotted fever pathogenesis. Our work highlights the crucial role of pso in enabling Rickettsia to evade immune surveillance during intracellular replication within endothelial cells, ultimately delaying pathogen-induced programmed cell death and escaping immune defense mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Infectious Diseases, Stony Brook University, Stony Brook, New York, United States of America.
- Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, United States of America.
ORCID-Profile: Hwan Keun Kim
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Stony Brook University
Zitieren
APA
Mishra, S., Helminiak, L., & Kim, H. K. (2025). Polysaccharide synthesis operon modulates Rickettsia-endothelial cell interactions. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013277
Vancouver
Mishra S, Helminiak L, Kim HK. Polysaccharide synthesis operon modulates Rickettsia-endothelial cell interactions. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013277
BibTeX
@article{Mishra2025,
author = {Mishra, Smruti and Helminiak, Luke and Kim, Hwan Keun},
title = {Polysaccharide synthesis operon modulates Rickettsia-endothelial cell interactions},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1013277}
}
EUVIMED